Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions.The company focuses on thrombosis, anesthetics and high potency and cytotoxics therapeutic categories.
It also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturing capabilities cover a range of product-types including oral solid dose, semi-solids, liquids, steriles, biological, active pharmaceutical ingredients (APIs) and infant nutritionals. The company has presence in Sub-Saharan Africa, Latin America, South East Asia, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.
Aspen Pharmacare Holdings Ltd (APN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Celiac Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Celiac Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Celiac Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Celiac Disease....
Ulcers Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Ulcers Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcers. Report includes...
257 pages •
By The Business Research Company
• Dec 2020
Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-viral drug therapy market. Description: Where is the largest and fastest growing...
Soluble Guanylate Cyclase - Pipeline Review, H2 2020 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target constitutes close to 29 molecules. Out of which approximately 26 molecules are developed by companies and remaining by the universities/institutes. The latest report Soluble...
The vaccines market was valued at US$ 39,128.3 million in 2019 and is projected to reach US$ 64,538.4 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027.The major driving factors are rising prevalence of infectious diseases, growing focus on immunization programs, and increasing support for vaccine development are...
Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen. There are two types of cytokines used to treat patients with cancer, namely, interferons (INFs) and interleukins (ILs). A third type, called hematopoietic...
Aspergillosis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Aspergillosis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Aspergillosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Aspergillosis....
Pompe Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Pompe Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Pompe Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.